CCG
SGFY

Cloverfields Capital Group’s Signify Health, Inc. SGFY Stock Holding History

Cloverfields Capital Group’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,808
Closed -$224K – 88
2022
Q4 		$224K Hold
7,808
– – 0.07% 72
2022
Q3 		$228K Buy
+7,808
New +$180K 0.08% 70

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Cloverfields Capital Group's SGFY Position: Q1 2023 in Review

Cloverfields Capital Group sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 7,808 shares — an estimated $224K sold.

Cloverfields Capital Group first reported a position in SGFY in Q3 2022 and held it in 2 quarters. The position peaked at $228K in Q3 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Cloverfields Capital Group reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cloverfields Capital Group sold 7,808 Signify Health, Inc. shares in Q1 2023, an estimated $224K.
  • Cloverfields Capital Group first reported a position in Signify Health, Inc. in Q3 2022 and held it in 2 quarters.
  • Cloverfields Capital Group's Signify Health, Inc. position peaked at $228K in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Cloverfields Capital Group's 13F filing for Q1 2023, filed 12 May 2023.